Skip to main content
. 2022 Jun 30;27(2):101–111. doi: 10.15430/JCP.2022.27.2.101

Figure 1. RNA-seq revealed transcriptome alteration by DATS treatment in the MCF-10A human mammary epithelial cell line and the SK-BR-3 human breast cancer cell line.

Figure 1

(A) Volcano scatter plots from MCF-10A and SK-BR-3 cell lines displaying genes upregulated or downregulated by 20 µM DATS treatment for 16 hours. (B) Venn diagram showing common and unique genes affected by DATS in each cell line. (C) Heatmap diagram showing differentially expressed genes by DATS treatment in MCF-10A and SK-BR-3 cell lines. DATS, diallyl trisulfide.